Tag: German biotech firm
WACKER to manufacture CureVac’s COVID-19 vaccine candidate in Amsterdam
German biotech firm CureVac and Wacker Chemie AG have signed a contract for the manufacturing of CureVac’s COVID-19 vaccine candidate CVnCoV.
CureVac is a biopharmaceutical...
Featured Article
Australian manufacturing in 2025: Challenges and pathways to progress
The Australian manufacturing sector, long considered the backbone of the nation’s economy, is standing at a crossroads in 2025.
